Clinical Trials

Now Enrolling

Glabellar Lines

A phase 1 study to evaluate the safety and efficacy of sequential administration of AGN-151586 and BOTOX® in subjects for treatment of moderate to severe Glabellar Lines (GL) in adult participants.

Abdomen Subcutaneous Fat

A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injections for reducing abdominal subcutaneous fat (Sumpreme-01) in adult participants.